{
    "2021-04-20": [
        [
            {
                "time": "",
                "original_text": "安图生物及二级子公司取得5项医疗器械注册证",
                "features": {
                    "keywords": [
                        "安图生物",
                        "医疗器械",
                        "注册证"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "安图生物现1笔大宗交易，共成交247.23万元",
                "features": {
                    "keywords": [
                        "安图生物",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "安图生物今日大宗交易成交2.10万股，成交价117.73元溢价0.0%",
                "features": {
                    "keywords": [
                        "安图生物",
                        "大宗交易",
                        "成交量",
                        "成交价",
                        "溢价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "平安证券---生物医药行业周报：第五批药品国采数据流出，集采成为常态符合预期【行业研究】",
                "features": {
                    "keywords": [
                        "平安证券",
                        "生物医药",
                        "行业周报",
                        "药品国采",
                        "集采"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}